Metraipolis › archive › dc_2bf9f404a3aa

Selective Benefit of Adjuvant Chemotherapy in Stage II dMMR Colon Cancer with High-Risk Features or Poorly Differentiated Histology: A Retrospective Study — Europe PMC PMID:41749882

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41749882
DOI
10.3390/cancers18040629
License (as archived)
solo-consultazione
Archived
2026-11-05T19:57:47.138Z
SHA-256 of the archived text
e0f8478bb5fa06e1c0754fc6637f40f1dc762488c3d27f348c5ac470e882ce0e
Stable URL of this page
https://metraipolis.com/documento/dc_2bf9f404a3aa

How to cite

Selective Benefit of Adjuvant Chemotherapy in Stage II dMMR Colon Cancer with High-Risk Features or Poorly Differentiated Histology: A Retrospective Study — Europe PMC PMID:41749882 — Europe PMC (en), https://europepmc.org/article/MED/41749882 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_2bf9f404a3aa (Metraipolis archive dc_2bf9f404a3aa, sha256 e0f8478bb5fa06e1c0754fc6637f40f1dc762488c3d27f348c5ac470e882ce0e)
BibTeX
@misc{dc2bf9f404a3aa,
  title = {Selective Benefit of Adjuvant Chemotherapy in Stage II dMMR Colon Cancer with High-Risk Features or Poorly Differentiated Histology: A Retrospective Study — Europe PMC PMID:41749882},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41749882},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_2bf9f404a3aa; sha256 e0f8478bb5fa06e1c0754fc6637f40f1dc762488c3d27f348c5ac470e882ce0e},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41749882. Agents can read the archived copy with the MCP tool read_document.